Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules
CA 2348153 A1 · Owner: U-Bisys B.V. · Inventors: Logtenberg, Ton; De Kruif, Cornelis Adriaan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
In one aspect the invention is concerned with the means and methods for providing a cell and/or a particle comprising a membrane derived from said cell with an additional proteinaceous molecule said process comprising , contacting said cell and/or said particle with a lipid-modified proteinaceous molecule, wherein said lipid-modified proteinaceous molecule comprises at least one protein moiety derived from a first protein and at least one lipidation signal derived from a second protein. In a preferred embodiment said lipid-modified proteinaceous molecule comprises a part of a molecule derived from the immune system. The invention further provides means and methods for the production …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 18, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 18, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 18, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.